Vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by ...

CTV News Channel is Canada's 24-hour all-news network. Watch the latest headlines from Canada and around the world.

and that they underestimated providers' preference for single-dose vials, which they didn't offer. Between the lines: Unlike ...

An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the ... [+] logo of US biotech company Novavax. Novavax’s vaccine targets the JN.1 COVID-19 variant ...

The Food and Drug Administration approved an updated coronavirus vaccine manufactured by Novavax Friday, days after new mRNA coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna ...

Novavax’s vaccine is based on protein technology, which takes longer to manufacture than mRNA vaccines like those made by Pfizer and BioNTech and Moderna. Protein-based vaccines work by getting ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Why Are Novavax Shares Trading Lower Today? Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know. Vaishali ...

The US Food and Drug Administration on Friday authorized an updated version of the protein-based Novavax Covid-19 vaccine for use in people 12 and up. Doses could be available by the end of next week.

As of 11:21 AM EDT. Market Open. Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best reward prospects ...